Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|July 25, 2026
Real-world evidence of baseline soluble CD25 as a prognostic biomarker and indicator of differential EGFR-TKI benefit in stage IV lung adenocarcinomaHuiru Guo, Lingshuang Liu, Veronika Lindberg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 26, 2013
Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?Weiwei Feng, Keqin Hua, Anais Malpica, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|December 24, 2005
Predictive testing of early CIN behaviour by molecular biomarkersJan P A Baak, Arnold-Jan Kruse, Emiel Janssen, et al.
Integrative Cancer Therapies|December 15, 2010
Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapyHuiru Guo, Jia Xiang Liu, Ling Xu, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 17, 2004
The relationship between syntactic structure analysis features, histological grade and high-risk HPV DNA in cervical intraepithelial neoplasiaArnold-Jan Kruse, Susanne Buhr-Wildhagen, Emiel A Janssen, et al.
Histopathology|February 22, 2013
Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcomaWeiwei Feng, Keqin Hua, Einar Gudlaugsson, et al.
Frontiers in Oncology|January 7, 2022
"How Long Have I Got?" in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This QuestionHuiru Guo, Hegen Li, Lihua Zhu, et al.
Integrative Cancer Therapies|June 20, 2025
Moxibustion Treatment, Alongside Conventional Western and Chinese Herbal Medical Therapies, May Improve Survival in Stage-IV Pulmonary Adenocarcinomas in a Dosage-Dependent Manner: A Prospective Observational Study With Propensity Score AnalysisHegen Li, Veronika Lindberg, Lihua Zhu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 13, 2023
In stage IV pulmonary adenocarcinoma patients, treatment with Traditional Chinese Medicine alone gives prognostically superior results to treatment with Platinum-Based Chemotherapy aloneHuiru Guo, Hegen Li, Lihua Zhu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 24, 2003
Prognostic value and reproducibility of koilocytosis in cervical intraepithelial neoplasiaArnold-Jan Kruse, Jan P A Baak, Tove Helliesen, et al.
Pageof 11